СОСТОЯНИЕ АНТИБИОТИКОРЕЗИСТЕНТНОСТИ KLEBSIELLA PNEUMONIAE

Q3 Medicine
Е. В. Анганова, А. В. Ветохина, Л. А. Распопина, Е. Л. Кичигина, Е. Д. Савилов
{"title":"СОСТОЯНИЕ АНТИБИОТИКОРЕЗИСТЕНТНОСТИ KLEBSIELLA PNEUMONIAE","authors":"Е. В. Анганова, А. В. Ветохина, Л. А. Распопина, Е. Л. Кичигина, Е. Д. Савилов","doi":"10.36233/0372-9311-2017-5-70-77","DOIUrl":null,"url":null,"abstract":"Klebsiella pneumoniae microorganisms belong to a group of the most prevalent clinically significant pathogens with a high level of antibacterial resistance (ESKAPE). The speed of formation of antibiotics-resistance by K. pneumoniae strains has sharply increased and reached pandemic scale. One of the main clinically significant mechanisms of antimicrobial resistance is (3-lactamase production, the groups being active depending on the region, country' and hospital. Currently, a significant part of nosocomial K. pneumoniae is resistant to penicillins, 11I-IV generation cephalosporins. The growth of resistance of klebsiellae to carbapenems is a serious threat to the healthcare system. First ofall, KPC-, OXA-, NDM-, VIM-, IMP-producing Widespread of carbapenem-resistant klebsiellae gives evidence on the necessity of international collaboration within the framework of antibiotics resistance control. An increase of frequency of obtained resistance of K. pneumoniae to non-(3-lactame antibiotics (fluoroquinolones, aminoglycosides) is noted. Isolates of K. pneumoniae resistant to tygecyclin, colistin are registered. In general, the problem of antibiotics resistance of causative agents of human diseases including K. pneumoniae continues to intensify. This is a serious threat to world public health that requires action in all sectors of the state.","PeriodicalId":24020,"journal":{"name":"Zhurnal mikrobiologii, epidemiologii, i immunobiologii","volume":"20 1","pages":"70-77"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhurnal mikrobiologii, epidemiologii, i immunobiologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36233/0372-9311-2017-5-70-77","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 5

Abstract

Klebsiella pneumoniae microorganisms belong to a group of the most prevalent clinically significant pathogens with a high level of antibacterial resistance (ESKAPE). The speed of formation of antibiotics-resistance by K. pneumoniae strains has sharply increased and reached pandemic scale. One of the main clinically significant mechanisms of antimicrobial resistance is (3-lactamase production, the groups being active depending on the region, country' and hospital. Currently, a significant part of nosocomial K. pneumoniae is resistant to penicillins, 11I-IV generation cephalosporins. The growth of resistance of klebsiellae to carbapenems is a serious threat to the healthcare system. First ofall, KPC-, OXA-, NDM-, VIM-, IMP-producing Widespread of carbapenem-resistant klebsiellae gives evidence on the necessity of international collaboration within the framework of antibiotics resistance control. An increase of frequency of obtained resistance of K. pneumoniae to non-(3-lactame antibiotics (fluoroquinolones, aminoglycosides) is noted. Isolates of K. pneumoniae resistant to tygecyclin, colistin are registered. In general, the problem of antibiotics resistance of causative agents of human diseases including K. pneumoniae continues to intensify. This is a serious threat to world public health that requires action in all sectors of the state.
肺炎克雷伯菌微生物属于一组最普遍的具有高水平抗菌耐药(ESKAPE)的临床重要病原体。肺炎克雷伯菌菌株抗生素耐药性的形成速度急剧增加,并达到大流行的规模。抗微生物药物耐药性的主要临床重要机制之一是(3-内酰胺酶)的产生,根据地区、国家和医院的不同,产生的群体是否活跃。目前,相当一部分医院感染的肺炎克雷伯菌对青霉素类、第11I-IV代头孢菌素耐药。克雷伯菌对碳青霉烯类耐药性的增长是对卫生保健系统的严重威胁。首先,KPC-、OXA-、NDM-、VIM-、imp -产碳青霉烯耐药克雷伯菌的广泛存在证明了在抗生素耐药性控制框架内开展国际合作的必要性。注意到肺炎克雷伯菌对非3-内酰胺类抗生素(氟喹诺酮类、氨基糖苷类)产生耐药性的频率有所增加。已登记肺炎克雷伯菌对加环素、粘菌素耐药的分离株。总的来说,包括肺炎克雷伯菌在内的人类疾病病原体的抗生素耐药性问题继续加剧。这是对世界公共卫生的严重威胁,需要国家所有部门采取行动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Zhurnal mikrobiologii, epidemiologii, i immunobiologii
Zhurnal mikrobiologii, epidemiologii, i immunobiologii Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
1.40
自引率
0.00%
发文量
51
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信